If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

NRIX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 6.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $214,655.77

Nurix Therapeutics Insider Trading History Chart

Nurix Therapeutics Share Price & Price History

^$13.08

▲ +0.05 (0.38%)

As of 10/3/2022 04:59 PM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Nurix Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2022	Christine Ring	General Counsel	Sell	712	$15.67	$11,157.04	4,615
8/1/2022	Gwenn Hansen	Insider	Sell	1,186	$15.67	$18,584.62	19,172
8/1/2022	Houte Hans Van	CFO	Sell	752	$15.67	$11,783.84	72,656
8/1/2022	Stefani Wolff	COO	Sell	356	$15.67	$5,578.52	1,238
5/2/2022	Christine Ring	General Counsel	Sell	660	$11.75	$7,755.00	3,403
5/2/2022	Gwenn Hansen	Insider	Sell	1,098	$11.75	$12,901.50	17,151
5/2/2022	Houte Hans Van	CFO	Sell	697	$11.75	$8,189.75	2,189
5/2/2022	Stefani Wolff	COO	Sell	330	$11.75	$3,877.50	632
12/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.04	$34,848.00
12/1/2021	Gwenn Hansen	Insider	Sell	400	$29.13	$11,652.00
11/1/2021	Gwenn Hansen	Insider	Sell	400	$33.24	$13,296.00
10/27/2021	Christine Ring	General Counsel	Sell	800	$35.25	$28,200.00
10/27/2021	Gwenn Hansen	Insider	Sell	400	$35.00	$14,000.00
10/11/2021	Christine Ring	General Counsel	Sell	1,200	$27.36	$32,832.00
10/1/2021	Gwenn Hansen	Insider	Sell	400	$29.92	$11,968.00
9/7/2021	Christine Ring	General Counsel	Sell	3,200	$35.25	$112,800.00
9/7/2021	Gwenn Hansen	Insider	Sell	1,600	$35.00	$56,000.00	15,797
8/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.87	$35,844.00	2,005
8/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.86	$223,950.00
8/2/2021	Gwenn Hansen	Insider	Sell	400	$31.21	$12,484.00	14,204
7/20/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00
7/12/2021	Pierre Beaurang	Insider	Sell	7,500	$23.92	$179,400.00	11,830
6/10/2021	Christine Ring	General Counsel	Sell	1,200	$29.40	$35,280.00	2,005
6/10/2021	Pierre Beaurang	Insider	Sell	7,500	$29.37	$220,275.00	11,830
6/1/2021	Gwenn Hansen	Insider	Sell	400	$27.74	$11,096.00	14,204
5/10/2021	Christine Ring	General Counsel	Sell	1,200	$27.00	$32,400.00	2,005
4/12/2021	Christine Ring	General Counsel	Sell	1,200	$27.20	$32,640.00	2,005
4/12/2021	Pierre Beaurang	Insider	Sell	7,500	$27.28	$204,600.00
4/5/2021	Gwenn Hansen	Insider	Sell	400	$35.00	$14,000.00	14,204
4/1/2021	Gwenn Hansen	Insider	Sell	400	$31.55	$12,620.00	14,204
3/16/2021	Gwenn Hansen	Insider	Sell	800	$45.00	$36,000.00	14,604
3/10/2021	Christine Ring	General Counsel	Sell	2,000	$41.27	$82,540.00
3/1/2021	Gwenn Hansen	Insider	Sell	800	$35.95	$28,760.00
2/22/2021	Houte Hans Van	CFO	Sell	5,330	$39.93	$212,826.90	1,417

How the Wealthy Elite are Picking Stocks

From Vantage Point | Ad

Grab your seat at our LIVE Training for traders. It’s your chance to learn how to pick the right stocks and find the market bottom.

We’ll reveal 3 Tips for conquering volatility and a few under-the-radar stocks we believe have significant potential in the long run.

Click here now to register.

>>>

SEC Filings (Institutional Ownership Changes) for Nurix Therapeutics (NASDAQ:NRIX)

95.74% of Nurix Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Nurix Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
8/22/2022	Legal & General Group Plc	12,173	$0.15M	0.0%	+35.9%	0.026%
8/18/2022	Goldman Sachs Group Inc.	331,843	$4.20M	0.0%	+5.1%	0.705%
8/17/2022	Nomura Holdings Inc.	306,001	$4.06M	0.0%	+0.2%	0.650%
8/16/2022	Thrivent Financial for Lutherans	15,177	$0.19M	0.0%	N/A	0.032%
8/16/2022	Price T Rowe Associates Inc. MD	4,620,823	$58.55M	0.0%	-3.9%	9.823%
8/16/2022	DAFNA Capital Management LLC	566,695	$7.18M	2.0%	+4.3%	1.205%
8/15/2022	State Street Corp	2,116,771	$26.82M	0.0%	-8.1%	4.500%
8/15/2022	Cubist Systematic Strategies LLC	68,684	$0.87M	0.0%	+15.3%	0.146%
8/15/2022	Bain Capital Life Sciences Investors LLC	1,822,883	$23.10M	2.7%	+41.9%	3.875%
8/15/2022	Millennium Management LLC	811,928	$10.29M	0.0%	+121.7%	1.726%
8/15/2022	Nomura Holdings Inc.	306,001	$4.06M	0.0%	+0.2%	0.650%
8/15/2022	UBS Asset Management Americas Inc.	244,305	$3.10M	0.0%	-3.5%	0.519%
8/13/2022	Renaissance Technologies LLC	118,400	$1.50M	0.0%	+55.4%	0.252%
8/13/2022	American International Group Inc.	20,752	$0.26M	0.0%	+33.5%	0.044%
8/12/2022	Northern Trust Corp	388,194	$4.92M	0.0%	+27.5%	0.825%
8/12/2022	Virtus ETF Advisers LLC	10,735	$0.14M	0.1%	+89.1%	0.023%
8/12/2022	Credit Suisse AG	15,619	$0.20M	0.0%	+7.9%	0.033%
8/12/2022	ClariVest Asset Management LLC	49,700	$0.63M	0.0%	N/A	0.106%
8/12/2022	Rafferty Asset Management LLC	71,049	$0.90M	0.0%	-51.4%	0.151%
8/12/2022	FMR LLC	1,790,655	$22.69M	0.0%	+59.6%	3.807%
8/12/2022	Rhumbline Advisers	63,039	$0.80M	0.0%	+88.1%	0.134%
8/11/2022	Trexquant Investment LP	10,350	$0.13M	0.0%	-76.7%	0.022%
8/11/2022	UBS Group AG	59,341	$0.75M	0.0%	-60.1%	0.126%
8/11/2022	Bank of Montreal Can	24,104	$0.29M	0.0%	N/A	0.051%
8/11/2022	JPMorgan Chase & Co.	129,525	$1.64M	0.0%	+7.5%	0.275%
8/9/2022	Swiss National Bank	79,000	$1M	0.0%	+66.3%	0.168%
8/9/2022	Pictet Asset Management SA	1,430,365	$18.12M	0.0%	-0.6%	3.041%
8/5/2022	State Board of Administration of Florida Retirement System	22,691	$0.29M	0.0%	N/A	0.048%
8/4/2022	TD Asset Management Inc.	43,259	$0.55M	0.0%	-31.5%	0.092%
8/4/2022	Jackson Creek Investment Advisors LLC	55,057	$0.88M	0.4%	N/A	0.117%
8/3/2022	Nisa Investment Advisors LLC	2,200	$28K	0.0%	-90.4%	0.005%
8/3/2022	Candriam S.C.A.	839,375	$10.63M	0.1%	+9.7%	1.784%
7/29/2022	SG Americas Securities LLC	34,221	$0.43M	0.0%	N/A	0.073%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	10,098	$0.13M	0.0%	N/A	0.021%
7/11/2022	ARK Investment Management LLC	778,725	$7.86M	0.0%	+98.7%	1.732%
6/30/2022	Amalgamated Bank	4,981	$70K	0.0%	N/A	0.011%
6/7/2022	Bank of America Corp DE	52,550	$0.74M	0.0%	-40.6%	0.117%
5/20/2022	The Manufacturers Life Insurance Company	66,700	$0.94M	0.0%	+307.2%	0.148%
5/18/2022	Nomura Holdings Inc.	305,340	$4.27M	0.0%	+72.8%	0.679%
5/17/2022	Alyeska Investment Group L.P.	120,750	$1.69M	0.0%	+5.0%	0.269%
5/17/2022	Quantbot Technologies LP	5,600	$78K	0.0%	+211.1%	0.012%
5/17/2022	Royal Bank of Canada	2,027	$28K	0.0%	-71.4%	0.005%
5/17/2022	Ensign Peak Advisors Inc	84,797	$1.19M	0.0%	+1,634.1%	0.189%
5/16/2022	California State Teachers Retirement System	30,372	$0.43M	0.0%	-10.1%	0.068%
5/16/2022	Goldman Sachs Group Inc.	315,666	$4.42M	0.0%	+2.3%	0.702%
5/16/2022	Blackstone Inc.	16,862	$0.24M	0.0%	+18.8%	0.038%
5/16/2022	Woodline Partners LP	219,281	$3.07M	0.0%	-63.0%	0.488%
5/16/2022	Wellington Management Group LLP	842,373	$11.80M	0.0%	-27.5%	1.874%
5/16/2022	State Street Corp	2,302,544	$32.26M	0.0%	+47.8%	5.122%
5/16/2022	Graham Capital Management L.P.	12,350	$0.17M	0.0%	N/A	0.027%
5/16/2022	UBS Group AG	148,704	$2.08M	0.0%	+49.7%	0.331%
5/16/2022	Hsbc Holdings PLC	11,615	$0.17M	0.0%	N/A	0.026%
5/13/2022	Renaissance Technologies LLC	76,200	$1.07M	0.0%	N/A	0.170%
5/13/2022	Northern Trust Corp	304,537	$4.27M	0.0%	-3.6%	0.678%
5/13/2022	Charles Schwab Investment Management Inc.	270,055	$3.78M	0.0%	+2.4%	0.601%
5/13/2022	Wasatch Advisors Inc.	1,546,689	$21.67M	0.1%	+28.5%	3.441%
5/13/2022	American International Group Inc.	15,550	$0.22M	0.0%	-6.6%	0.035%
5/13/2022	Parkman Healthcare Partners LLC	20,663	$0.29M	0.1%	-76.5%	0.046%
5/13/2022	Candriam Luxembourg S.C.A.	765,106	$10.72M	0.1%	-3.7%	1.702%
5/13/2022	Vanguard Group Inc.	2,028,063	$28.41M	0.0%	+1.9%	4.512%
5/13/2022	Dimensional Fund Advisors LP	237,525	$3.33M	0.0%	+104.1%	0.528%
5/12/2022	BlackRock Inc.	2,524,643	$35.37M	0.0%	-0.9%	5.617%
5/12/2022	Rhumbline Advisers	33,511	$0.47M	0.0%	+4.9%	0.075%
5/12/2022	Metropolitan Life Insurance Co NY	2,128	$30K	0.0%	-76.4%	0.005%
5/12/2022	MetLife Investment Management LLC	18,670	$0.26M	0.0%	+58.5%	0.042%
5/12/2022	Citigroup Inc.	25,180	$0.35M	0.0%	-67.1%	0.056%
5/11/2022	JPMorgan Chase & Co.	120,516	$1.69M	0.0%	+34.1%	0.268%
5/11/2022	Jennison Associates LLC	43,755	$0.61M	0.0%	-95.2%	0.097%
5/11/2022	GSA Capital Partners LLP	15,963	$0.22M	0.0%	N/A	0.036%
5/10/2022	ProShare Advisors LLC	10,489	$0.15M	0.0%	-20.1%	0.023%
5/10/2022	TD Asset Management Inc.	63,131	$0.88M	0.0%	-29.6%	0.140%
5/10/2022	TRV GP Iii LLC	1,922,549	$26.94M	7.3%	-20.6%	4.277%
5/9/2022	Swiss National Bank	47,500	$0.67M	0.0%	+8.0%	0.106%
5/9/2022	Qube Research & Technologies Ltd	33,003	$0.46M	0.0%	N/A	0.073%
5/4/2022	Prospera Financial Services Inc	4,211	$59K	0.0%	N/A	0.009%
4/29/2022	Nisa Investment Advisors LLC	22,800	$0.32M	0.0%	N/A	0.051%
4/28/2022	DekaBank Deutsche Girozentrale	14,000	$0.20M	0.0%	+10.2%	0.031%
4/21/2022	Zurcher Kantonalbank Zurich Cantonalbank	5,118	$72K	0.0%	+26.5%	0.011%
4/19/2022	ARK Investment Management LLC	391,991	$5.49M	0.0%	+792.0%	0.872%
2/25/2022	EDBI Pte Ltd	7,442	$0.22M	0.1%	N/A	0.017%
2/19/2022	Woodline Partners LP	592,941	$17.17M	0.2%	+331.5%	1.325%
2/16/2022	Wasatch Advisors Inc.	1,203,589	$34.84M	0.1%	+2.7%	2.690%
2/14/2022	Virtus ETF Advisers LLC	6,010	$0.17M	0.1%	-16.4%	0.013%
2/14/2022	Redmile Group LLC	2,958,284	$85.64M	1.9%	-4.4%	6.612%
2/14/2022	Point72 Asset Management L.P.	136,550	$3.95M	0.0%	N/A	0.305%
2/14/2022	Soleus Capital Management L.P.	743,238	$21.52M	2.2%	+181.6%	1.661%
2/14/2022	Eventide Asset Management LLC	1,870,000	$54.14M	0.7%	+55.8%	4.180%
2/14/2022	Fiduciary Trust Co.	9,862	$0.29M	0.0%	+47.6%	0.022%
2/11/2022	Ponoi II Management LLC	327,123	$9.47M	17.2%	-41.7%	0.731%
2/11/2022	Ponoi Management LLC	327,122	$9.47M	8.7%	-41.7%	0.731%
2/11/2022	Ensign Peak Advisors Inc	4,890	$0.14M	0.0%	+512.0%	0.011%
2/10/2022	Candriam Luxembourg S.C.A.	794,103	$22.99M	0.1%	+43.1%	1.775%
2/10/2022	Rhumbline Advisers	31,938	$0.93M	0.0%	+2.8%	0.071%
2/10/2022	Pictet Asset Management SA	1,121,935	$32.48M	0.0%	+21.0%	2.508%
2/10/2022	Rafferty Asset Management LLC	90,706	$2.63M	0.0%	+54.1%	0.203%
2/10/2022	Citigroup Inc.	76,611	$2.22M	0.0%	-36.5%	0.171%
2/10/2022	TD Asset Management Inc.	89,737	$2.60M	0.0%	+30.1%	0.201%
2/10/2022	WINTON GROUP Ltd	11,509	$0.33M	0.0%	-15.7%	0.026%
2/9/2022	AlphaCrest Capital Management LLC	9,842	$0.29M	0.0%	N/A	0.022%
2/9/2022	Dimensional Fund Advisors LP	116,358	$3.37M	0.0%	N/A	0.260%

Data available starting January 2016

Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malignancies and autoimmune diseases; and NX-1607, an orally available Casitas B-lineage lymphoma proto-oncogene-B (CBL-B) inhibitor for immuno-oncology indications. It also develops NX-0255, a CBL-B inhibitor for ex vivo use to enhance adoptive T-cell therapy; and DeTIL-0255 that is in the Phase 1 clinical trial for the treatment of gynecologic cancers, including ovarian, endometrial, and cervical cancer. The company has a strategic collaboration agreement with Gilead Sciences, Inc. for cancer and other challenging diseases patients; and Sanofi S.A. The company was formerly known as Nurix Inc. and changed its name to Nurix Therapeutics, Inc. in October 2018. The company was incorporated in 2009 and is headquartered in San Francisco, California.

Today's Range

Now: $13.08

$12.98

$13.45

50 Day Range

MA: $15.81

$12.33

$19.81

52 Week Range

Now: $13.08

$7.52

$36.24

Volume

10,250 shs

Average Volume

477,519 shs

Market Capitalization

$615.31 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.84

Who are the company insiders with the largest holdings of Nurix Therapeutics?: Nurix Therapeutics' top insider investors include:
Houte Hans Van (CFO)
Gwenn Hansen (Insider)
Pierre Beaurang (Insider)
Christine Ring (General Counsel)
Stefani Wolff (COO)
Learn More about top insider investors at Nurix Therapeutics.